Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore B Moore

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
Pediatrics|January 27, 2019
Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017George S Amatuni, Robert J Currier, Joseph A Church, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Neurology|June 6, 2024
Neurocognitive outcome in children with sickle cell disease after myeloimmunoablative conditioning and haploidentical hematopoietic stem cell transplantation: a non-randomized clinical trialSuzanne Braniecki, Elliott Vichinsky, Mark C Walters, et al.
Blood Advances|April 20, 2026
Clinical Outcomes of Lentiviral Vector Gene Therapy for Sickle Cell DiseaseChattip Prueksapraopong, Augustine Fernandes, Beatriz Campo Fernandez, et al.
Frontiers in Immunology|December 26, 2022
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell diseaseYaya Chu, Julie-An Talano, Lee Ann Baxter-Lowe, et al.
Cell|March 17, 2023
HIV-1 remission and possible cure in a woman after haplo-cord blood transplantJingmei Hsu, Koen Van Besien, Marshall J Glesby, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Bone Marrow Transplantation|May 7, 2021
Stable to improved cardiac and pulmonary function in children with high-risk sickle cell disease following haploidentical stem cell transplantationDeborah Friedman, Allen J Dozor, Jordan Milner, et al.
Pediatrics|January 27, 2019
Newborn Screening for Severe Combined Immunodeficiency and T-cell Lymphopenia in California, 2010-2017George S Amatuni, Robert J Currier, Joseph A Church, et al.
Blood|January 9, 2007
ABT-869, a multitargeted receptor tyrosine kinase inhibitor: inhibition of FLT3 phosphorylation and signaling in acute myeloid leukemiaDeepa B Shankar, Junling Li, Paul Tapang, et al.
Blood|June 3, 2026
Long-term stability of posttranscriptional genetic silencing of BCL11A using a shmiR vector in Sickle Cell DiseaseErica B Esrick, Leslie Lehmann, Amy Federico, et al.
Pageof 9